Puede usar las teclas derecha/izquierda para votar el artículo.Votación:1 estrella2 estrellas3 estrellas4 estrellas5 estrellas (2 votos, promedio: 5.00 sobre 5)
LoadingLoading...

Health

A preliminary study indicates that mild cases of COVID-19 generate immunity

New York / A study by Mount Sinai Hospital in New York, still pending a last review by the scientific community, concludes that the vast majority of mild cases of COVID-19 generate antibodies for a time, which would allow people who they have passed the disease without fear of contagion.

The study has been published in a preliminary way in “MedRxiv” and it has involved fifteen scientists from the prestigious New York hospital, including the director of the research, the Spanish pathologist Carlos Cordón-Cardó.

The research was done on 1,434 candidates who had passed the disease or believed they had passed it. “People with confirmed or suspected SARS-CoV-2 infection were examined by PCR to detect the presence of the viral genome and by an enzyme-linked immunosorbent assay to detect the presence of antibodies against the SARS-CoV-2 peak,” explains the study.

The result was that all but three confirmed SARS-CoV-2 patients, 624 people, “seroconverted to the peak of SARS-CoV-2, while only 37.4% of patients suspected of SARS-CoV-2 seroconverted.”

The data obtained with the first group, that of those confirmed with the virus, means that 98% generated antibodies, although it is still unknown for how long. In any case, “PCR positivity was detected up to 28 days after resolution of symptoms.

Scientists at Mount Sinai Hospital have thus concluded that “the vast majority of COVID19 confirmed patients seroconvert, potentially providing immunity to reinfection.” (May 12, 2020, EFE / PracticaEspañol)

(Automatic translation)

The related video news (April 27, 2020):


Comprensión

Lee la noticia y responde a las preguntas

Congratulations - you have completed Lee la noticia y responde a las preguntas.

You scored %%SCORE%% out of %%TOTAL%%.

Your performance has been rated as %%RATING%%


Your answers are highlighted below.
Question 1
El texto habla de...
A
un estudio sobre unos pacientes de COVID-19 que generaron unos anticuerpos contra esta enfermedad.
B
un tratamiento que se está probando en pacientes con COVID-19.
C
cuál es la función de los anticuerpos en el cuerpo humano.
Question 2
En el texto se dice que...
A
toda la comunidad científica sostiene que las personas que hayan tenido COVID-19 son ya inmunes a ese virus.
B
ese estudio indica que unos pacientes leves de COVID-19 generaron anticuerpos que les hicieron inmunes.
C
no es cierto que algunos pacientes leves de COVID-19 hayan generado anticuerpos que les hicieron inmunes.
Question 3
Sobre esa investigación se dice que...
A
fue realizada con personas que pasaron el COVID-19 y también con aquellas que creyeron haberlo tenido y superado.
B
solo la hicieron con personas que creyeron haber tenido el COVID-19.
C
la realizaron con personas que aún no han superado el COVID-19.
Question 4
En el texto se dice que...
A
casi todos generaron esos anticuerpos.
B
solo un pequeño porcentaje de esos pacientes generó esos anticuerpos.
C
los científicos aseguran que esas personas serán inmunes para siempre.
Question 5
En el vídeo se dice que...
A
la capital de EE.UU. es el epicentro de la epidemia en el país.
B
está bajando la tasa de mortalidad por COVID-19 en el estado de Nueva York.
C
más de la mitad de los neoyorkinos ya han pasado el COVID-19.
Once you are finished, click the button below. Any items you have not completed will be marked incorrect. Get Results
There are 5 questions to complete.

Noticias al azar